Exploring Fragment Adding Strategies to Enhance Molecule Pretraining in AI-Driven Drug Discovery

被引:5
|
作者
Meng, Zhaoxu [1 ]
Chen, Cheng [2 ]
Zhang, Xuan [2 ]
Zhao, Wei [3 ]
Cui, Xuefeng [2 ]
机构
[1] Shandong Univ, Sch Life Sci, Qingdao 266237, Peoples R China
[2] Shandong Univ, Sch Comp Sci & Technol, Qingdao 266237, Peoples R China
[3] Shandong Univ, State Key Lab Microbial Technol, Qingdao 266237, Peoples R China
来源
BIG DATA MINING AND ANALYTICS | 2024年 / 7卷 / 03期
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
Drugs; Task analysis; Databases; Training; Chemicals; Vocabulary; Fingerprint recognition; pretraining; information retrieval; drug discovery; virtual screening; molecule property prediction;
D O I
10.26599/BDMA.2024.9020003
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
The effectiveness of Al-driven drug discovery can be enhanced by pretraining on small molecules. However, the conventional masked language model pretraining techniques are not suitable for molecule pretraining due to the limited vocabulary size and the non-sequential structure of molecules. To overcome these challenges, we propose FragAdd, a strategy that involves adding a chemically implausible molecular fragment to the input molecule. This approach allows for the incorporation of rich local information and the generation of a high-quality graph representation, which is advantageous for tasks like virtual screening. Consequently, we have developed a virtual screening protocol that focuses on identifying estrogen receptor alpha binders on a nucleus receptor. Our results demonstrate a significant improvement in the binding capacity of the retrieved molecules. Additionally, we demonstrate that the FragAdd strategy can be combined with other self-supervised methods to further expedite the drug discovery process.
引用
收藏
页码:565 / 576
页数:12
相关论文
共 50 条
  • [1] AI-driven target selection in drug discovery - exploring the undiscovered country
    Oprea, Tudor
    Ursu, Oleg
    Bologa, Cristian
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [2] AI-Driven Drug Discovery for Rare Diseases
    Gangwal, Amit
    Lavecchia, Antonio
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2024, : 2214 - 2231
  • [3] From part to whole: AI-driven progress in fragment- based drug discovery
    Yoo, Jinhyeok
    Jang, Wonkyeong
    Shin, Woong-Hee
    CURRENT OPINION IN STRUCTURAL BIOLOGY, 2025, 91
  • [4] AI-Driven Drug Discovery Straddles the Virtual and the Real
    Grinstein J.D.
    Tilmans N.
    Nwankwo J.
    Park J.
    Genetic Engineering and Biotechnology News, 2024, 44 (04): : 38 - 41
  • [5] GFlowNets for AI-driven scientific discovery
    Jain, Moksh
    Deleu, Tristan
    Hartford, Jason
    Liu, Cheng-Hao
    Hernandez-Garcia, Alex
    Bengio, Yoshua
    DIGITAL DISCOVERY, 2023, 2 (03): : 557 - 577
  • [6] AI-driven drug discovery: A boon against COVID-19?
    Kaushik, Aman Chandra
    Raj, Utkarsh
    AI OPEN, 2020, 1 : 1 - 4
  • [7] Molecular representations in AI-driven drug discovery: a review and practical guide
    David, Laurianne
    Thakkar, Amol
    Mercado, Rocio
    Engkvist, Ola
    JOURNAL OF CHEMINFORMATICS, 2020, 12 (01)
  • [8] Strategic partnerships for AI-driven drug discovery: The role of relational dynamics
    Kint, Stefan
    Dolfsma, Wilfred
    Robinson, Douglas
    DRUG DISCOVERY TODAY, 2024, 29 (12)
  • [9] Molecular representations in AI-driven drug discovery: a review and practical guide
    Laurianne David
    Amol Thakkar
    Rocío Mercado
    Ola Engkvist
    Journal of Cheminformatics, 12
  • [10] Exploring AI-Driven Drug Repurposing Strategies Targeting ErbB Signalling Pathway for Brain Cancer Therapy
    Ng, Chi Kit
    Long, Jianqiao
    Tang, Muran
    Li, Jichun
    Quan, Mingming
    2024 IEEE INTERNATIONAL CONFERENCE ON CYBERNETICS AND INTELLIGENT SYSTEMS, CIS AND IEEE INTERNATIONAL CONFERENCE ON ROBOTICS, AUTOMATION AND MECHATRONICS, RAM, CIS-RAM 2024, 2024, : 555 - 560